BioCentury
ARTICLE | Company News

Archemix, Ribomic Inc. deal

August 18, 2008 7:00 AM UTC

The partners expanded a 2006 deal to give Ribomic a non-exclusive, worldwide license to use Archemix’s aptamer technology to develop aptamer therapeutics against undisclosed targets. The original deal...